Stéphane Bancel (born 1972/1973) is a French businessman and the CEO and 9% owner of Moderna, an American biotechnology company.
Bancel was born in France and earned his master's degrees in engineering from École Centrale Paris, and the University of Minnesota.[1] He went on to earn an MBA from Harvard Business School.[2]
Bancel was a sales director at Eli Lilly and Company, eventually becoming head of operations for Belgium.[2] In 2007, he became CEO of French diagnostics company BioMérieux.[2]
In 2016 Bancel joined Moderna, becoming CEO. Stat news, reported that Bancel led a highly secretive culture with little outside review of its science or research.[2]
In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion.[1]